Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Part of paid clinical trials in Basking Ridge, New Jersey.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT06915116
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Cancer
  • Period Problem

Eligibility Criteria

Sex
FEMALE
Age
15 Years - 40 Years
Healthy Volunteers
Not accepted

Interventions

  • Acupuncture — PROCEDURE
    Acupuncture will be delivered by licensed experienced acupuncturists at MSK. The intervention includes 12 treatments of acupuncture over 12 weeks (i.e. one treatment a week) with a +/- 14-day window. This window applies to the 12-week treatment period rather than to individual visits. The minimum required time between each treatment is 48 hours. When patients experience menses recovery during the treatment period, they have the option to discontinue treatment or continue receiving up to 12 acupuncture sessions for symptom management over 12 weeks.
  • No Acupuncture — OTHER
    Will have the option to receive the same acupuncture treatment as the acupuncture group after a 16-week waiting period

Study Details

The purpose of this study is to find out whether it is practical (feasible) to use acupuncture to treat period loss (amenorrhea) caused by chemotherapy treatment in people with cancer. The researchers will look at how many participants enroll and complete the study. The researchers will also study how treatment with acupuncture affects the amount of time for the menstrual cycle to return and symptoms and quality of life related to amenorrhea.

Key Dates

Start date
Mar 31, 2025
Status verified
Apr 2026
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Acupuncture group
    Participants in the acupuncture group will receive 12 acupuncture treatments over 12 weeks during the study.
  • Active Comparator: Wait-list Control (WLC)
    Participants in the wait-list control group will be put on a wait-list and have the option to receive the same acupuncture treatment as the acupuncture group after a 16-week waiting period. The 16-week waiting period will begin on the day that the WLC participant completes their baseline lab draw.

Primary Outcome Measure

Enrollment rate [ Time Frame: 1 year ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)Basking RidgeNew Jersey07920
Jun Mao, MD, MSCE
646-608-8553
Memorial Sloan Kettering Monmouth (All protocol activities)MiddletownNew Jersey07748
Jun Mao, MD, MSCE
646-608-8553
Memorial Sloan Kettering Bergen (All Protocol Activities)MontvaleNew Jersey07645
Jun Mao, MD, MSCE
646-608-8553
Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities)CommackNew York11725
Jun Mao, MD, MSCE
646-608-8553
Memorial Sloan Kettering Westchester (All Protocol Activities)HarrisonNew York10604
Jun Mao, MD, MSCE
646-608-8553
Memorial Sloan Kettering Cancer Center (All Protocol Activities)New YorkNew York10065
Jun Mao, MD, MSCE
646-608-8553
William Tap, MD
646-888-4163
Memorial Sloan Kettering Nassau (All Protocol Activities)Rockville CentreNew York11553
Jun Mao, MD, MSCE
646-608-8553

Find similar trials in Basking Ridge, NJ

By research site
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (All protocol activities)· Middletown, NJMemorial Sloan Kettering Bergen (All Protocol Activities)· Montvale, NJMemorial Sloan Kettering Suffolk- Commack (All Protocol Activities)· Commack, NYMemorial Sloan Kettering Westchester (All Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center (All Protocol Activities)· New York, NY

Related Studies